Adcendo is a biotech company focused on developing antibody-drug conjugates for treating cancers with high unmet needs.

Kivu Bioscience is a biotech company developing next-generation antibody-drug conjugates for cancer treatment.

Aro Biotherapeutics is a clinical stage biotech company specializing in the development of tissue-targeted genetic medicines, including a potential treatment for Pompe Disease and new therapies for autoimmune disorders, using their proprietary Centyrin-siRNA platform.

Rampart Bioscience is a biotechnology company developing next-generation biologics using their proprietary DNA-based medicines platform, HALO, with a focus on treating hypophosphatasia.